Biosimilar for HER2+ breast cancer achieves similar overall response rate to referenc - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Biosimilar for HER2+ breast cancer achieves similar overall response rate to referenc

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

11-22-2019, 02:07 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,941	Biosimilar for HER2+ breast cancer achieves similar overall response rate to referenc The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously untreated metastatic breast cancer, according to a large, randomized phase III study reported at the ESMO Asia 2019 Congress. More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 03:53 PM.

free webpage hit counter